Skip to main content
Article thumbnail
Location of Repository

Baicalin Improves Survival in a Murine Model of Polymicrobial Sepsis via Suppressing Inflammatory Response and Lymphocyte Apoptosis

By Jiali Zhu, Jiafeng Wang, Ying Sheng, Yun Zou, Lulong Bo, Fei Wang, Jingsheng Lou, Xiaohua Fan, Rui Bao, Youping Wu, Feng Chen, Xiaoming Deng and Jinbao Li
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1995). A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group.
    2. (2008). Apoptosis in sepsis: mechanisms, clinical impact and potential therapeutic targets.
    3. (2003). Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports.
    4. (2011). Baicalein, an active component of Scutellaria baicalensis Georgi, improves cardiac contractile function in endotoxaemic rats via induction of heme oxygenase-1 and suppression of inflammatory responses.
    5. (2008). Baicalin inhibits macrophage activation by lipopolysaccharide and protects mice from endotoxin shock.
    6. (2008). Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis.
    7. (2000). Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte.
    8. (2007). Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis.
    9. (2011). Diagnostic and prognostic biomarkers of sepsis in critical care.
    10. (2009). Effect of baicalin on inflammatory mediator levels and microcirculation disturbance in rats with severe acute pancreatitis.
    11. (1995). Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.
    12. (2007). Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China.
    13. (2005). Genetic polymorphisms and sepsis.
    14. (2011). In vitro synergistic effects of baicalin with oxytetracycline and tetracycline against Staphylococcus aureus.
    15. (2006). Increased Natural CD4 +CD25 + Regulatory T Cells and Their Suppressor Activity Do Not Contribute to Mortality in Murine Polymicrobial Sepsis.
    16. (2008). Inflammation, endothelium, and coagulation in sepsis.
    17. Linden A (2004) Interleukin-17 family members and inammation.
    18. (2009). Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages.
    19. (2009). Molecular biology of inflammation and sepsis: a primer.
    20. (2010). Multiple therapeutic effects of adjunctive baicalin therapy in experimental bacterial meningitis.
    21. (2002). Myocardial apoptosis and ischemic preconditioning.
    22. (2006). Neutrophils in development of multiple organ failure in sepsis.
    23. (2009). New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin.
    24. (2003). Overexpression of Bcl-2 provides protection in septic mice by a trans effect.
    25. (2006). Pathogen recognition and innate immunity.
    26. (2009). Pathological changes in multiple organs of rats with severe acute pancreatitis treated by baicalin and octreotide.
    27. (2010). PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction.
    28. (1994). Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial.
    29. (2002). Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fi brosis in mice.
    30. (2010). Sepsis biomarkers: a review.
    31. (2003). Simultaneous activation of apoptosis and inflammation in pathogenesis of septic shock: a hypothesis.
    32. (1996). Sir Isaac Newton, sepsis,
    33. (2002). The biochemistry and medical significance of the avonoids.
    34. (2003). The epidemiology of sepsis in the United States from
    35. (2010). The systemic proinflammatory response in sepsis.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.